Data sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study

Página do item simplificado
dc.contributor.authorLopes, Luciane C.
dc.contributor.authorSalas, Maribel
dc.contributor.authorOsorio-de-Castro, Claudia Garcia Serpa
dc.contributor.authorLeal, Lisiane Freitas
dc.contributor.authorDoubova, Svetlana V.
dc.contributor.authorCañás, Martín
dc.contributor.authorDreser, Anahi
dc.contributor.authorAcosta, Angela
dc.contributor.authorBaldoni, Andre Oliveira
dc.contributor.authorBergamaschi, Cristiane de Cássia
dc.contributor.authorMota, Daniel Marques
dc.contributor.authorGomez-Galicia, Diana L.
dc.contributor.authorSepúlveda-Viveros, Dino
dc.contributor.authorDelgado, Edgard Narvaez
dc.contributor.authorLima, Elisangela da Costa
dc.contributor.authorChandia, Felipe Vera
dc.contributor.authorFerre, Felipe
dc.contributor.authorMarin, Gustavo H.
dc.contributor.authorOlmos, Ismael
dc.contributor.authorZimmermann, Ivan R.
dc.contributor.authorFulone, Izabela
dc.contributor.authorRoldán-Saelzer, Juan
dc.contributor.authorSánchez-Salgado, Juan Carlos
dc.contributor.authorCastro-Pastrana Lucila I.
dc.contributor.authorSouza, Luiz Jupiter Carneiro de
dc.contributor.authorBeltrán, Manuel Machado
dc.contributor.authorSilva, Marcus Tolentino
dc.contributor.authorMena, María Belén
dc.contributor.authorFonteles, Marta Maria de
dc.contributor.authorUrtasun, Martín A.
dc.contributor.authorTarapués, Monica
dc.contributor.authorHernández, Patricia Granja
dc.contributor.authorMedero, Natalia
dc.contributor.authorHerrera-Comoglio, Raquel
dc.contributor.authorBarberato-Filho, Silvio
dc.contributor.authorGalvão, Taís Freire
dc.contributor.authorLuiza, Vera Lucia
dc.contributor.authorSanta-Ana-Tellez, Yared
dc.contributor.authorRodríguez - Tanta, Yesenia
dc.contributor.authorElseviers, Monique
dc.date.accessioned2024-11-12T18:53:06Z
dc.date.available2024-11-12T18:53:06Z
dc.date.issued2022
dc.description.abstractPurpose: Drug utilization research (DUR) contributes to inform policymaking and to strengthen health systems. The availability of data sources is the first step for con- ducting DUR. However, documents that systematize these data sources in Latin American (LatAm) countries are not known. We compiled the potential data sources for DUR in the LatAm region. Methods: A network of DUR experts from nine LatAm countries was assembled and experts conducted: (i) a website search of the government, academic, and private health institutions; (ii) screening of eligible data sources, and (iii) liaising with national experts in pharmacoepidemiology (via an online survey). The data sources were char- acterized by accessibility, geographic granularity, setting, sector of the data, sources and type of the data. Descriptive analyses were performed. Results: We identified 125 data sources for DUR in nine LatAm countries. Thirty- eight (30%) of them were publicly and conveniently available; 89 (71%) were accessi- ble with limitations, and 18 (14%) were not accessible or lacked clear rules for data access. From the 125 data sources, 76 (61%) were from the public sector only; 46 (37%) were from pharmacy records; 43 (34%) came from ambulatory settings and; 85 (68%) gave access to individual patient-level data. Conclusions: Although multiple sources for DUR are available in LatAm countries, the accessibility is a major challenge. The procedures for accessing DUR data should be transparent, feasible, affordable, and protocol-driven. This inventory could permit a comparison of drug utilization between countries identifying potential medication- related problems that need further exploration.
dc.identifier.citationLopes LC, Salas M, Osorio-de-Castro CGS, Leal LF, Doubova SV, Cañás M, Dreser A, Acosta A, Baldoni AO, de Cássia Bergamaschi C, Mota DM, Gómez-Galicia DL, Sepúlveda-Viveros D, Delgado EN, da Costa Lima E, Chandia FV, Ferre F, Marin GH, Olmos I, Zimmermann IR, Fulone I, Roldán-Saelzer J, Sánchez-Salgado JC, Castro-Pastrana LI, de Souza LJC, Beltrán MM, Silva MT, Mena MB, de França Fonteles MM, Urtasun MA, Tarapués M, Hernández PG, Medero N, Herrera-Comoglio R, Barberato-Filho S, Galvão TF, Luiza VL, Santa-Ana-Tellez Y, Rodríguez-Tanta Y, Elseviers M. Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study. Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):343-352. doi: 10.1002/pds.5404.
dc.identifier.otherDOI: 10.47538/AC-2021.02-11
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/595
dc.language.isoen
dc.publisherPharmacoepidemiology and Drug Safety
dc.subjectcross-nationalen
dc.subjectdrug utilization researchen
dc.subjectLatin Americaen
dc.subjectpharmacoepidemiologyen
dc.titleData sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Lopes LC et al_Pharmacoepidemiol Drug Saf UnB.pdf
Tamanho:
13.18 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar
Coleções
Produção Docente